Role of Vasopressin in the Regulation of Renal Sodium Excretion: Interaction with Glucagon-Like Peptide-1-Reference-Cited by-同舟云学术

Role of Vasopressin in the Regulation of Renal Sodium Excretion: Interaction with Glucagon-Like Peptide-1

Published:2016-04 Issue:4 Volume:28 Page:
ISSN:0953-8194
Container-title:Journal of Neuroendocrinology
language:en
Short-container-title:J Neuroendocrinol

Author:

Kutina A. V.¹,Golosova D. V.¹,Marina A. S.¹,Shakhmatova E. I.¹,Natochin Y. V.¹

Affiliation:

1. Laboratory of Renal Physiology and Water-Salt Balance; Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences; Saint-Petersburg Russia

Funder

Russian Science Foundation

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jne.12367/fullpdf

Reference56 articles.

1. Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct;Schafer;Am J Physiol Renal Physiol,2002

2. Natriuretic response of the rat to plasma concentrations of arginine vasopressin within the physiological range;Balment;J Physiol,1984

3. Arginine vasopressin increases renal sodium excretion in the anesthetized rat through V1 receptors;Musabayane;Ren Fail,1997

4. Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists;Perucca;J Am Soc Nephrol,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Neurohypophysial Hormones on Protein Excretion by the Kidneys;Journal of Evolutionary Biochemistry and Physiology;2023-09

2. Effect of Neurohypophyseal Hormones on Excretion of Proteins by the Kidneys;Российский физиологический журнал им И М Сеченова;2023-09-01

3. Subtypes of neurohypophyseal nonapeptide receptors and their functions in rat kidneys;Acta Naturae;2020-04-16

4. Vasopressin receptor subtypes and renal sodium transport;Vitamins and Hormones;2020

5. Cardiovascular effects of glucagon-like peptide 1 receptor agonists: from mechanistic studies in humans to clinical outcomes;Cardiovascular Research;2019-12-11